Literature DB >> 20148342

Transglutaminase 2: a multi-functional protein in multiple subcellular compartments.

Donghyun Park1, Sun Shim Choi, Kwon-Soo Ha.   

Abstract

Transglutaminase 2 (TG2) is a multifunctional protein that can function as a transglutaminase, G protein, kinase, protein disulfide isomerase, and as an adaptor protein. These multiple biochemical activities of TG2 account for, at least in part, its involvement in a wide variety of cellular processes encompassing differentiation, cell death, inflammation, cell migration, and wound healing. The individual biochemical activities of TG2 are regulated by several cellular factors, including calcium, nucleotides, and redox potential, which vary depending on its subcellular location. Thus, the microenvironments of the subcellular compartments to which TG2 localizes, such as the cytosol, plasma membrane, nucleus, mitochondria, or extracellular space, are important determinants to switch on or off various TG2 biochemical activities. Furthermore, TG2 interacts with a distinct subset of proteins and/or substrates depending on its subcellular location. In this review, the biological functions and molecular interactions of TG2 will be discussed in the context of the unique environments of the subcellular compartments to which TG2 localizes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20148342     DOI: 10.1007/s00726-010-0500-z

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  55 in total

1.  Proteomic and transcriptomic analysis of heart failure due to volume overload in a rat aorto-caval fistula model provides support for new potential therapeutic targets - monoamine oxidase A and transglutaminase 2.

Authors:  Jiri Petrak; Jana Pospisilova; Miroslava Sedinova; Petr Jedelsky; Lucie Lorkova; Ondrej Vit; Michal Kolar; Hynek Strnad; Jan Benes; David Sedmera; Ludek Cervenka; Vojtech Melenovsky
Journal:  Proteome Sci       Date:  2011-11-11       Impact factor: 2.480

2.  The transglutaminase type 2 and pyruvate kinase isoenzyme M2 interplay in autophagy regulation.

Authors:  Sara Altuntas; Federica Rossin; Claudia Marsella; Manuela D'Eletto; Laura Diaz-Hidalgo; Maria Grazia Farrace; Michelangelo Campanella; Manuela Antonioli; Gian Maria Fimia; Mauro Piacentini
Journal:  Oncotarget       Date:  2015-12-29

Review 3.  Transglutaminase 2-mediated serotonylation in pulmonary hypertension.

Authors:  K C Penumatsa; B L Fanburg
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-12-27       Impact factor: 5.464

4.  Transglutaminase Is Required for Epidermal Squamous Cell Carcinoma Stem Cell Survival.

Authors:  Matthew L Fisher; Jeffrey W Keillor; Wen Xu; Richard L Eckert; Candace Kerr
Journal:  Mol Cancer Res       Date:  2015-05-01       Impact factor: 5.852

5.  Transglutaminase 2 ablation leads to mitophagy impairment associated with a metabolic shift towards aerobic glycolysis.

Authors:  F Rossin; M D'Eletto; L Falasca; S Sepe; S Cocco; G M Fimia; M Campanella; P G Mastroberardino; M G Farrace; M Piacentini
Journal:  Cell Death Differ       Date:  2014-07-25       Impact factor: 15.828

6.  The vicious cycle between transglutaminase 2 and reactive oxygen species in hyperglycemic memory-induced endothelial dysfunction.

Authors:  Jee-Yeon Lee; Yeon-Ju Lee; Hye-Yoon Jeon; Eun-Taek Han; Won Sun Park; Seok-Ho Hong; Young-Myeong Kim; Kwon-Soo Ha
Journal:  FASEB J       Date:  2019-08-28       Impact factor: 5.191

Review 7.  Cellular functions of tissue transglutaminase.

Authors:  Maria V Nurminskaya; Alexey M Belkin
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

8.  Tissue transglutaminase-1 promotes stemness and chemoresistance in gastric cancer cells by regulating Wnt/β-catenin signaling.

Authors:  Haitao Huang; Zhiqi Chen; Xiuqin Ni
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-04

9.  Integrative proteomic profiling of protein activity and interactions using protein arrays.

Authors:  Se-Hui Jung; Kangseung Lee; Deok-Hoon Kong; Woo Jin Kim; Young-Myeong Kim; Kwon-Soo Ha
Journal:  Mol Cell Proteomics       Date:  2012-07-26       Impact factor: 5.911

10.  Inhibition of allergic inflammation by supplementation with 5-hydroxytryptophan.

Authors:  Hiam Abdala-Valencia; Sergejs Berdnikovs; Christine A McCary; Daniela Urick; Riti Mahadevia; Michelle E Marchese; Kelsey Swartz; Lakiea Wright; Gökhan M Mutlu; Joan M Cook-Mills
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-07-27       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.